Search

Displaying results 8781 - 8790 of 9686 in total
  1. Drug

    MK-4830

    go.drugbank.com/drugs/DB17454
    Investigational

    MK-4830 is a monoclonal antibody that targets the myeloid-specific immunoglobulin-like transcript (ILT) 4 receptor.

  2. Drug

    Inetetamab

    go.drugbank.com/drugs/DB17457
    Investigational

    Inetetamab is a trastuzumab analog. It differs from trastuzumab by a two amino acid variation in its Fc domain (allotype variation), and possesses an exact F(ab’)2 of trastuzumab.

  3. Drug

    TASO-001

    go.drugbank.com/drugs/DB17463
    Investigational

    TASO-001 is a transforming growth factor (TGF)-beta 2 specific antisense oligodeoxynucleotide.

  4. Drug

    KF-0210

    go.drugbank.com/drugs/DB17476
    Investigational

    KF-0210 is a small molecule developed by Keythera Pharmaceuticals. It is being investigated for cancers.

  5. Drug

    BI-836880

    go.drugbank.com/drugs/DB17484
    Investigational

    BI-836880 is a humanized bispecific nanobody that targets VEGF and Ang2.

  6. Drug

    CPGJ602

    go.drugbank.com/drugs/DB17485
    Investigational

    CPGJ602 is a recombinant anti-EGFR human-mouse chimeric monoclonal antibody.

  7. Drug

    NY-ESO-1 peptide vaccine

    go.drugbank.com/drugs/DB17498
    Investigational

    It contains a peptide derived from the cancer-testis antigen (NY-ESO-1).

  8. Drug

    DSP107

    go.drugbank.com/drugs/DB17501
    Investigational

    DSP107 is a bi-functional, trimeric, fusion protein composed of sequences from the extracellular domain of SIRPα and 4-1BBL.

  9. Drug

    M-701

    go.drugbank.com/drugs/DB17504
    Experimental

    M-701 is a recombinant anti-EpCAM/CD3 bispecific antibody.

  10. Drug

    VB10.16

    go.drugbank.com/drugs/DB17512
    Investigational

    It is composed of three parts, one encodes the E6/E7 fusion protein of human papillomavirus (HPV) type 16 (HPV16), a dimerization entity, and the part encoding a protein that specifically binds to antigen-presenting … VB10.16 is a novel therapeutic antigen-presenting cell-targeting DNA vaccine developed to treat HPV16-positive cancers.